CaSRevolution
Milan, Italy· Est.
A novel disease-modifying approach against neurodegeneration
Private Company
Total funding raised: $2.5M
About
A novel disease-modifying approach against neurodegeneration
CRISPRGene Therapy
Funding History
1Total raised:$2.5M
Seed$2.5M